Marek’s disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek’s disease lymphomas

References

1. Akiyama Y., Kato S. 1974; Two cell lines from lymphomas of Marek’s disease. Biken Journal 17:105–116
   [Google Scholar]
2. Anderson A. S., Francesconi A., Morgan R. W. 1992; Complete nucleotide sequence of the Marek’s disease virus ICP4 gene. Virology 189:657–667
   [Google Scholar]
3. Baigent S., Ross L. J. N., Davison T. F. 1996; A flow cytometric method for identifying Marek’s disease virus pp38 expression in lymphocyte subpopulations. Avian Pathology 25:255–267
   [Google Scholar]
4. Burgess S. C., Kaiser P., Davison T. F. 1997; A novel lympho-blastoid surface antigen and its role in Marek’s disease. In Proceedings of 5th International Symposium on Marek’s disease East Lansing, Michigan, USA: in press
   [Google Scholar]
5. Cantello J. L., Anderson A. S., Morgan R. W. 1994; Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek’s disease virus. Journal of Virology 68:6280–6290
   [Google Scholar]
6. Calnek B. W., Shek W. R., Schat K. A. 1981; Spontaneous and induced herpesvirus genome expression in Marek’s disease tumour cell lines. Infection and Immunity 34:483–491
   [Google Scholar]
7. Chan M. M., Chen C.-L. H., Ager L. L., Cooper M. D. 1988; Identification of the avian homologues of mammalian CD4 and CD8 antigens. Journal of Immunology 140:2133–2138
   [Google Scholar]
8. Cui Z., Lee L. F., Liu J.-L., Kung H. J. 1991; Structural analysis and transcriptional mapping of the Marek’s disease virus gene encoding pp38, an antigen associated with transformed cells. Journal of Virology 65:6509–6515
   [Google Scholar]
9. Daly C., Reich N. C. 1995; Characterization of specific DNA- binding factors activated by double-stranded RNA as positive regulators of interferon α/β-stimulated genes. Journal of Biological Chemistry 270:23739–23746
   [Google Scholar]
10. Davidson I., Borovskaya A., Perl S., Malkinson M. 1995; Use of the polymerase chain reaction for the diagnosis of natural infection of chickens and turkeys with Marek’s disease virus and reticuloendotheliosis virus. Avian Pathology 24:69–94
    [Google Scholar]
11. Delecluse H.-J., Schuller S., Hammerschmidt W. 1993; Latent Marek’s disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells. EMBO Journal 12:3277–3286
    [Google Scholar]
12. Jones D., Lee L. F., Liu J.-L., Kung H. J., Tillotson J. 1992; Marek’s disease virus encodes a basic leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumours. Proceedings of the National Academy of Sciences, USA 89:4042–4046
    [Google Scholar]
13. Kaiser P., Rothwell L., Baigent S., Davison T. F. 1996; Characterisation of an antigen expressed on Marek’s disease tumour cells. In Poultry Immunology Davison T. F., Morris T. R., Payne L. N. Edited by Abingdon, UK: Carfax Science Publishers;
    [Google Scholar]
14. Kawamura M., Hayashi M., Furuichi T., Nonoyama M., Isogai E., Namioka S. 1991; The inhibitory effects of oligonucleotides complementary to Marek’s disease virus mRNA transcribed from the BamHI-H region on the proliferation of transformed lymphoblastoid cells, MDCC-MSB1. Journal of General Virology 72:1105–1111
    [Google Scholar]
15. Kopacek J., Ross L. J. N., Zelnik V., Pastorek J. 1993; The 132 bp repeats are present in RNA transcripts from 1·8 kb gene family of Marek’s disease virus-transformed cells. Acta Virologica 37:191–195
    [Google Scholar]
16. Koptidesova D., Kopacek J., Zelnik V., Ross L. J. N., Pastorekova S., Pastorek J. 1995; Identification and characterization of a cDNA clone derived from the Marek’s disease tumour cell line RPL1 encoding a homologue of α-transducing factor (VP16) of HSV-1. Archives of Virology 140:355–362
    [Google Scholar]
17. Li D. S., Pastorek J., Zelnik V., Smith G. D., Ross L. J. N. 1994; Identification of novel transcripts complementary to the Marek’s disease virus homologue of the ICP4 gene of herpes simplex virus. Journal of General Virology 75:1713–1722
    [Google Scholar]
18. McColl K., Calnek B. W., Harris W. V., Schat K. A., Lee L. F. 1987; Expression of a putative tumour-associated antigen on normal versus Marek’s disease virus-transformed lymphocytes. Journal of the National Cancer Institute 79:991–1000
    [Google Scholar]
19. McKie E. A., Ubukata E., Hasegawa S., Zhang S., Nonoyama M., Tanaka A. 1995; The transcripts from the sequences flanking the short component ofMarek’s disease virus during latent infection form a unique family of 3′ coterminal RNAs. Journal of Virology 69:1310–1314
    [Google Scholar]
20. Maotani K., Kanamori A., Ikuta K., Ueda S., Kato S., Hirai K. 1986; Amplification of a tandem direct repeat within inverted repeats of Marek’s disease virus DNA during serial in vitro passage. Journal of Virology 58:657–660
    [Google Scholar]
21. Naito M., Nakajima K., Iwa N., Ono K., Yoshida I., Konobe T., Ikuta K., Ueda S., Kato S., Hirai K. 1986; Demonstration of a Marek’s disease virus-specific antigen in tumour lesions of chickens with Marek’s disease using monoclonal antibody against a virus phosphorylated protein. Avian Pathology 15:503–510
    [Google Scholar]
22. Nazerian K., Stephens E. A., Sharma J. M., Lee L. F., Gailitis M., Witter R. L. 1977; A non-producer T lymphoblastoid cell line from Marek’s disease transplantable tumour (JMV). Avian Diseases 21:69–76
    [Google Scholar]
23. Ohashi K., Zhou W., O’Connell P. H., Schat K. A. 1994; Characterization of a Marek’s disease virus BamHI-A-specific cDNA clone obtained from a Marek’s disease lymphoblastoid cell line. Virology 199:275–283
    [Google Scholar]
24. Payne L. N., Howes K., Rennie M., Bumstead J. M., Kidd A. W. 1981; Use of an agar culture technique for establishing lymphoid cell lines from Marek’s disease lymphomas. International Journal of Cancer 28:756–766
    [Google Scholar]
25. Peng Q., Shirazi Y. 1996a; Isolation and characterization of Marek’s disease virus (MDV) cDNAs from an MDV-transformed lymphoblastoid cell line : identification of an open reading frame antisense to the MDV Eco-Q protein (Meq). Virology 221:368–374
    [Google Scholar]
26. Peng Q., Shirazi Y. 1996b; Characterization of the protein product encoded by a splicing variant of the Marek’s disease virus Eco-Q gene (Meq). Virology 226:77–82
    [Google Scholar]
27. Peng Q., Donovan J., Specter S., Tanaka A., Nonoyama M. 1993; Prolonged proliferation ofprimary chicken embryo fibroblasts transfected with cDNAs from the BamHI-H gene family of Marek’s disease virus. International Journal of Oncology 3:587–591
    [Google Scholar]
28. Powell P. C., Payne L. N., Frazier J. A., Rennie M. 1974; T lymphoblastoid cell lines from Marek’s disease lymphomas. Nature 251:79–80
    [Google Scholar]
29. Powell P. C., Howes K., Lawn A. M., Mustill B. M., Payne L. N., Rennie M., Thompson M. A. 1984; Marek’s disease in turkeys: the induction of lesions and the establishment of lymphoid cell lines. Avian Pathology 13:201–214
    [Google Scholar]
30. Qian Z., Brunovskis P., Raucher F. III Lee L., Kung H.-J. 1995; Transactivation activity of Meq, a Marek’s disease herpesvirus bZip protein persistently expressed in latently infected transformed T cells. Journal of Virology 69:4037–4044
    [Google Scholar]
31. Qian Z., Brunovskis P., Lee L., Vogt P. K., Kung H.-J. 1996; Novel DNA binding specificities of a putative herpesvirus bZip oncoprotein. Journal of Virology 70:7161–7170
    [Google Scholar]
32. Ross L. J. N., Powell P. C., Walker D. J., Rennie M., Payne L. N. 1977; Expression of virus-specific, thymus-specific and tumour-specific antigens in lymphoblastoid cell lines derived from Marek’s disease lymphomas. Journal of General Virology 35:219–235
    [Google Scholar]
33. Schat K. A., Calnek B. W., Fabricant J. 1982; Characterisation of two highly oncogenic strains of Marek’s disease virus. Avian Pathology 11:593–605
    [Google Scholar]
34. Schat K. A., Chen C. L., Calnek B. W., Char D. 1991; Transformation of T lymphocyte subsets by Marek’s disease herpesvirus. Journal of Virology 65:1408–1413
    [Google Scholar]
35. Sekellick M. J., Marcus P. I. 1986; Induction of high titer chicken interferon. Methods in Microbiology 119:115–125
    [Google Scholar]
36. Silva R. F., Witter R. L. 1985; Induction of high titer chicken interferon. Methods in Enzymology 119:115–125
    [Google Scholar]
37. Volpini L. M., Calnek B. W., Sekellick M. J., Marcus P. I. 1995; Stages of Marek’s disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression. Veterinary Microbiology 47:99–109
    [Google Scholar]
38. Witter R. L., Stephens E. A., Sharma J. M., Nazerian K. 1975; Demonstration of a tumour-associated surface antigen in Marek’s disease. Journal of Immunology 115:177–183
    [Google Scholar]
39. Xie Q., Anderson A. S., Morgan R. W. 1996; Marek’s disease virus (MDV) ICP4, pp38 and meq genes are involved in the maintenance of transformation of MDCC MSB-1 MDV-transformed lymphoblastoid cells. Journal of Virology 70:1125–1131
    [Google Scholar]